Name: TGTX Income Statement - Tg Therapeutics Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

TGTX - Tg Therapeutics, Inc.

USD | NASDAQ | Healthcare

TGTX Income Statement - Tg Therapeutics Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	204.9	192.6	161.7	141.1	120.9	108.2	83.9	73.5	63.5	44.0	165.8	16.1	7.8	0.1	0.1	0.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Revenues
Revenues	700.3	616.3	329.0	233.7	2.8	6.7	0.2	0.2	0.2	0.2	0.2	-	-	-	-	-
Cost of Revenue	118.7	100.7	38.5	14.1	0.3	0.8	-	-	-	-	-	-	-	-	-	-
Gross Profit	581.7	515.6	290.5	219.5	2.5	5.9	-	-	-	-	-	-	-	-	-	-
Operating Expenses
Research & Development	162.2	160.2	94.3	76.2	125.4	222.6	165.9	154.2	159.4	102.5	69.2	47.7	40.1	13.7	21.0
Operating Income
Operating Income	149.5	123.3	41.9	20.6	(218.3)	(344.8)	(273.6)	(169.1)	(174.4)	(118.7)	(79.0)	(63.2)	(55.7)	(23.0)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	0.9	0.3	0.3	0.2	0.1	0.0	-	-
Tax & Net
Income Tax Expense	(339.6)	(339.8)	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
Per Share
EPS Basic	3.20	3.10	0.16	0.09	(1.65)	(2.63)	(2.42)	-	-	-	-	-	-	-	-	-
Supplementary Data
EBITDA	-	123.4	42.0	20.8	(218.0)	(344.5)	(273.4)	(169.0)	(174.3)	(118.6)	(78.9)	(63.2)	(55.7)	(23.0)	(26.9)	(0.9)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	48.4	41.2	40.9	31.8	46.4	23.9	20.1	17.6	32.7	17.4	14.8	28.1	15.9	29.6	20.8	26.9	48.0	62.6	52.0	44.9	63.1	43.0	50.5	36.4	36.0	30.9	58.0	32.9	32.4	52.3	33.4	38.7	35.0	26.0	27.1	26.7	22.7	22.3	21.8	13.5
Selling General & Administrative	88.2	62.7	63.4	55.6	50.3	39.0	42.0	38.8	34.6	31.2	32.8	30.7	28.1	48.0	14.3	12.6
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	0.0	-	-	-	0.0	-	-	-	0.0	-	-	-	0.1	-	-	-
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	0.1	-	-	-	0.1
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	170.1	142.1	132.3	106.3	112.2	78.2	71.4	64.7	72.7	56.5	51.0	60.7	44.8	52.1	35.1	39.5

Operating Income
Operating Income	34.8	50.5	29.4	34.8	8.6	29.9	12.4	8.8	(9.3)	(12.5)	114.8	(44.7)	(37.0)	(77.5)	(35.0)	(38.9)	(66.9)	(92.9)	(85.1)	(77.5)	(89.2)	(86.8)	(85.7)	(50.8)	(50.2)	(38.0)	(60.9)	(35.5)	(34.7)	(142.8)	(34.3)	44.3	(41.6)	(31.0)	(31.6)	(28.4)	(27.7)	(24.0)	(24.9)	(16.0)

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.1	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1
Interest Expense	7.7	6.5	6.7	6.7	6.8	6.9	10.8	4.0	2.3	2.4	3.7	3.6	2.8	2.9	1.6	3.0	2.7	1.1
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(14.4)	(5.4)	(3.5)	(3.9)	(3.2)	(4.5)	(8.2)	(2.3)	(1.4)	(1.5)	(0.9)	(2.9)	(2.2)	(0.9)	(0.9)	(1.6)	(2.1)
Pre-Tax Income	20.4	45.1	25.9	30.9	5.5	25.5	4.3	6.6	(10.7)	(14.0)	113.9	(47.6)	(39.2)	-	-	-	-

Tax & Net
Income Tax Expense	0.6	22.1	(365.0)	2.7	0.4	2.1	0.4	(0.3)	0.0	-	0.0	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	19.8	23.0	390.9	28.2	5.1	23.3	3.9	6.9	(10.7)	(14.4)	113.9	(47.6)	(39.2)	(53.0)	(35.8)	(40.5)	(69.0)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	19.8	23.0	390.9	28.2	5.1	23.3	3.9	6.9	(10.7)	(14.4)	113.9	(47.6)	(39.2)	(53.0)	(35.8)	(40.5)	(69.0)
Net Income Attributable To Parent	19.8	23.0	390.9	28.2	5.1	23.3	3.9	6.9	(10.7)	(14.4)	113.9	(47.6)	(39.2)	(78.5)	(35.8)	(40.5)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	19.8	23.0	390.9	28.2	5.1	23.3	3.9	6.9	(10.7)	(14.4)	113.9	(47.6)	(39.2)	(78.5)	(35.8)

Per Share
EPS Basic	0.14	-	2.69	0.19	0.03	-	0.03	0.05	(0.07)	-	0.80	(0.34)	(0.28)	-	(0.26)	(0.30)	(0.51)	-	(0.65)	(0.59)	(0.69)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	0.12	-	2.43	0.17	0.03	-	0.02	0.04	(0.07)	-	0.73	(0.34)	(0.28)	-	(0.26)	(0.30)	(0.51)	-
Shares Basic	144.4	-	145.4	146.7	146.7	-	145.1	144.7	146.2	-	142.9	141.5	140.3	-	135.3	134.8	134.4	-
Shares Diluted	160.1	-	161.0	162.6	162.8	-	160.7	159.4	146.2	-	155.9	141.5	140.3	-	135.3	134.8	134.4	-